x

Viridian Therapeutics, Inc.\DE (Nasdaq:VRDN)

Health Care/Life Sciences • Biotechnology
CIK 1590750
Company

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Address
221 Crescent Street
Suite 401
Waltham, Massachusetts 02453
Employees
96
Stock Info
Close
$18.11
Day Range
17.92 - 19.21
52 Week Range
10.93 - 33.00
Average volume
951.14K
Short Interest
7.75M (02/15/24)
% of Float Shorted
14.21%
Market Cap
$1.2B
Revenue
$314K
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
$3,270.83
P/E Ratio
N/A
EPS
-$5.32
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Tomas Kiselak
President, Chief Executive Officer & Director
Stephen Frank Mahoney MBA
Director
Sarah Gheuens MD, PhD
Director
Jennifer K Moses CPA
Independent Director
Arlene M Morris
Independent Director
Peter Harwin
SEC filings
DateFormEvent
12 Aug, 2024 S-8
8 Aug, 2024 10-Q
8 Aug, 2024 8-K
15 Jul, 2024 8-K
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
20 Jun, 2024 8-K
10 Jun, 2024 DEFA14A
8 May, 2024 10-Q
8 May, 2024 8-K
26 Apr, 2024 ARS
26 Apr, 2024 DEFA14A
26 Apr, 2024 DEF 14A
16 Apr, 2024 8-K
1 Apr, 2024 4
1 Apr, 2024 SC 13D/A
28 Feb, 2024 S-8
27 Feb, 2024 10-K
27 Feb, 2024 8-K
14 Feb, 2024 4
14 Feb, 2024 3
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
7 Feb, 2024 4
29 Jan, 2024 SC 13G/A
29 Jan, 2024 SC 13G
24 Jan, 2024 4
24 Jan, 2024 SC 13D/A
24 Jan, 2024 SC 13G
17 Jan, 2024 424B5
12 Jan, 2024 3
10 Jan, 2024 SC 13G
8 Jan, 2024 8-K
18 Dec, 2023 144
18 Dec, 2023 8-K
12 Dec, 2023 144
8 Dec, 2023 SC 13G
7 Dec, 2023 144
1 Dec, 2023 144
30 Nov, 2023 S-3ASR
16 Nov, 2023 144
13 Nov, 2023 10-Q
13 Nov, 2023 4
13 Nov, 2023 8-K
3 Nov, 2023 SC 13D/A
2 Nov, 2023 8-K
1 Nov, 2023 3
1 Nov, 2023 3
1 Nov, 2023 4
1 Nov, 2023 4
1 Nov, 2023 4
30 Oct, 2023 8-K CEO Change
25 Sep, 2023 8-K
25 Sep, 2023 3
25 Sep, 2023 4
19 Sep, 2023 3
12 Sep, 2023 8-K
8 Aug, 2023 10-Q
8 Aug, 2023 S-8
24 Jul, 2023 S-3ASR
17 Jul, 2023 8-K
10 Jul, 2023 8-K
16 Jun, 2023 4
16 Jun, 2023 8-K
16 Jun, 2023 4
16 Jun, 2023 4
16 Jun, 2023 4
14 Jun, 2023 SC 13D/A
6 Jun, 2023 4
2 Jun, 2023 144
11 May, 2023 SC 13G
10 May, 2023 10-Q
9 May, 2023 8-K
28 Apr, 2023 DEFA14A
28 Apr, 2023 ARS
28 Apr, 2023 DEF 14A
12 Apr, 2023 4
12 Apr, 2023 8-K
13 Mar, 2023 4
10 Mar, 2023 8-K
10 Mar, 2023 4
10 Mar, 2023 S-8
9 Mar, 2023 10-K
8 Mar, 2023 8-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
10 Feb, 2023 4
10 Feb, 2023 4
10 Feb, 2023 4
10 Feb, 2023 4
9 Feb, 2023 SC 13G
7 Feb, 2023 4
7 Feb, 2023 3
7 Feb, 2023 4/A
6 Feb, 2023 8-K CEO Change
3 Feb, 2023 4
3 Feb, 2023 SC 13G
26 Jan, 2023 SC 13G/A
25 Jan, 2023 4
18 Jan, 2023 4
11 Jan, 2023 4
9 Jan, 2023 8-K
22 Dec, 2022 4
19 Dec, 2022 4
14 Dec, 2022 4
16 Nov, 2022 4
14 Nov, 2022 10-Q
9 Sep, 2022 S-3ASR
19 Aug, 2022 4
19 Aug, 2022 8-K
19 Aug, 2022 SC 13D/A
18 Aug, 2022 424B5
17 Aug, 2022 424B3
16 Aug, 2022 S-8 POS
16 Aug, 2022 S-8
16 Aug, 2022 S-8 POS
16 Aug, 2022 8-K
15 Aug, 2022 8-K
15 Aug, 2022 424B5
15 Aug, 2022 10-Q
12 Aug, 2022 SC 13G/A
24 Jun, 2022 3
23 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
2 Jun, 2022 4
31 May, 2022 SC 13G
19 May, 2022 SC 13G
13 May, 2022 10-Q
12 May, 2022 8-K
4 May, 2022 4
27 Apr, 2022 DEFA14A
27 Apr, 2022 DEF 14A
5 Apr, 2022 4
5 Apr, 2022 8-K
11 Mar, 2022 S-8
11 Mar, 2022 10-K
10 Mar, 2022 8-K
3 Mar, 2022 4
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G/A
4 Feb, 2022 SC 13G/A
3 Feb, 2022 4
3 Feb, 2022 4
3 Feb, 2022 4
3 Feb, 2022 4
28 Jan, 2022 SC 13G/A
3 Jan, 2022 4
10 Dec, 2021 4
17 Nov, 2021 EFFECT
15 Nov, 2021 CORRESP
10 Nov, 2021 UPLOAD
8 Nov, 2021 8-K
8 Nov, 2021 S-3
5 Nov, 2021 10-Q
4 Nov, 2021 8-K
28 Oct, 2021 SC 13G
14 Oct, 2021 SC 13G
8 Oct, 2021 SC 13G/A
4 Oct, 2021 3
30 Sep, 2021 SC 13G
29 Sep, 2021 SC 13G/A
29 Sep, 2021 SC 13G/A
28 Sep, 2021 4
24 Sep, 2021 SC 13G
24 Sep, 2021 SC 13G/A
23 Sep, 2021 4
23 Sep, 2021 SC 13D/A
23 Sep, 2021 8-K
22 Sep, 2021 424B5
20 Sep, 2021 424B5
10 Sep, 2021 SC 13G
26 Aug, 2021 SC 13G
26 Aug, 2021 3
12 Aug, 2021 10-Q
11 Aug, 2021 8-K
27 Jul, 2021 3
27 Jul, 2021 3
27 Jul, 2021 4
26 Jul, 2021 8-K
15 Jul, 2021 3
15 Jul, 2021 8-K
15 Jul, 2021 4
16 Jun, 2021 4
16 Jun, 2021 4
16 Jun, 2021 4
15 Jun, 2021 8-K/A
4 Jun, 2021 8-K
4 Jun, 2021 DEFA14A
1 Jun, 2021 SC 13G/A
17 May, 2021 8-K
10 May, 2021 SC 13G
7 May, 2021 10-Q
6 May, 2021 8-K
30 Apr, 2021 DEF 14A
26 Apr, 2021 8-K
23 Apr, 2021 424B5
23 Apr, 2021 424B3
14 Apr, 2021 PRE 14A
26 Mar, 2021 10-K
26 Mar, 2021 S-8
25 Mar, 2021 8-K
15 Mar, 2021 SC 13G/A
10 Mar, 2021 SC 13G
19 Feb, 2021 SC 13G
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G/A
8 Feb, 2021 4
8 Feb, 2021 4
8 Feb, 2021 4
8 Feb, 2021 4
8 Feb, 2021 4
21 Jan, 2021 3
21 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 8-K CEO Change
20 Jan, 2021 4
19 Jan, 2021 4
19 Jan, 2021 4
19 Jan, 2021 SC 13G
15 Jan, 2021 4
11 Jan, 2021 SC 13G
11 Jan, 2021 SC 13G
7 Jan, 2021 SC 13G
5 Jan, 2021 SC 13D
4 Jan, 2021 8-K
21 Dec, 2020 UPLOAD
21 Dec, 2020 CORRESP
18 Dec, 2020 UPLOAD
8 Dec, 2020 CORRESP
7 Dec, 2020 UPLOAD
20 Nov, 2020 PRE 14A
Last update:2024-03-06 13:43:49.147056
Viridian Therapeutics, Inc.\DE by TradingView

Sign Up to Subscribe